Novartis receives positive CHMP opinion for Jakavi® to treat acute and chronic graft-versus-host disease
CHMP opinion based on Phase III REACH2 and REACH3 trials that showed Jakavi improved response rates and failure-free survival compared...
Month: March 2022
Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe
Positive opinion paves way for third indication in Europe for Kymriah, a potentially definitive single infusion CAR-T cell therapy treatment...
Dermavant Showcases New Long-Term Durability and Tolerability Data from Phase 3 PSOARING 3 Trial of Tapinarof Cream for Adults with Plaque Psoriasis at the 2022 AAD Annual Meeting
Tapinarof demonstrated continued improvements for up to 52 weeks in efficacy outcomes, quality of life measures, and tolerability scores with...
Noema Pharma to Attend and Present at Stifel 2022 CNS Days
BASEL, Switzerland, March 25, 2022 (GLOBE NEWSWIRE) -- Noema Pharma, a Swiss-based clinical-stage company targeting orphan and large-market central nervous...
Icosavax Announces Topline Interim Phase 1/2 Results for IVX-411 Against SARS-CoV-2
- Immunologic response observed in both SARS-CoV-2 naive and previously vaccinated subjects, but lower than expected and inconsistent with known...
Morphic Therapeutic Announces Initiation of EMERALD-1 Phase 2a Clinical Trial of MORF-057 in Patients with Ulcerative Colitis
MORF-057, an oral α4β7 integrin inhibitor candidate, holds potential for treating inflammatory bowel diseases Phase 2b EMERALD-2 clinical trial of...
ORYZON to Give Updates on Corporate Progress in March and April
Virtual Bio-Europe Spring 2022Kempen Life Sciences Conference Asebio Investor DayMADRID, Spain and CAMBRIDGE, Mass., March 25, 2022 (GLOBE NEWSWIRE) --...
Timber Pharmaceuticals Announces Late-Breaking Presentation at the American Academy of Dermatology 2022 Annual Meeting
Sub-analysis of the Phase 2b CONTROL study in congenital ichthyosis demonstrates treatment success with TMB-001 regardless of subtype BASKING RIDGE,...
Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients
PARSORTIX SHOWS POTENTIAL FOR IDENTIFYING THERAPEUTIC TARGETS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCERParsortix system harvests intact CTCs for whole...
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Collaboration builds on commitment to advance personalised healthcare by helping to improve access to new treatment options for patients with...
HSA Group, Yemen wins two Stevie Awards – awarded Gold for its response to COVID-19
DUBAI, United Arab Emirates, March 25, 2022 /PRNewswire/ -- HSA Group, Yemen ('HSA'), Yemen's largest and leading private company and part...
CGTN: Peng Liyuan addresses video conference on World TB Day 2022
BEIJING, March 24, 2022 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill...
Sonendo, Inc. to Present at Piper Sandler & Co. Dental Day
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced...
Poko Group (UK) Ltd. Enters Distribution Deal With JM Wholesale Of Leicester, UK
Second Large Distribution Deal Signed As Poko Ships Orders throughout the British Isles and EuropeCompany Is Currently in Discussions with...
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
GOTHENBURG, SE / ACCESSWIRE / March 24, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)The shareholders in XVIVO Perfusion AB (publ), reg....
Cloud DX Signs Two Contracts with US Primary Care Clinics
Continued growth in US RPM as partner Maxwell Telecare signs two additional clinics in IllinoisNews in SummaryThese RPM contracts bring...
Dynatronics Corporation to Participate in Maxim Group’s 2022 Virtual Growth Conference
EAGAN, MN / ACCESSWIRE / March 24, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
Nymbl Science Hosts March 31 Webinar, “Cost, Quality, and Member Experience: Why Addressing Mobility Transforms Your Health Plan”
Falls account for 6-8% of Medicare Advantage expenditures DENVER--(BUSINESS WIRE)--Nymbl Science, an innovative health technology company dedicated to preventing falls,...
Psyched Wellness and the National Research Council of Canada Announce Preliminary Data from Studies of Neuroprotective Properties of AME-1
Toronto, Ontario--(Newsfile Corp. - March 24, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Neovasc Announces Consolidation and Extension of Convertible Debt
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a...